FDA Launches Pilot Program to Speed Early Clinical Trials
The FDA's Expedited Investigational New Drug (IND) Pilot pairs drug sponsors with research institutions to reduce startup delays for early human studies.
The FDA's Expedited Investigational New Drug (IND) Pilot pairs drug sponsors with research institutions to reduce startup delays for early human studies.
A recent cruise ship outbreak of the Andes strain underscores the potential for silent spread and severe respiratory complications in travel networks.
A new scientific statement from the Endocrine Society emphasizes health outcomes such as sleep apnea and heart disease over weight loss alone.
Children with an inherited risk for COPD show slower lung growth when exposed to higher levels of air pollution during early childhood.